首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1555527

認知診斷市場，按診斷、按指示、按最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Cognitive Diagnostics Market, By Diagnosis, By Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年08月04日 | 出版商:

AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告要點

2023年認知診斷市場規模為53.9021億美元，2024年至2032年複合年成長率為27.90%。

認知診斷市場-市場動態

全球老年人口的成長和認知障礙盛行率的增加預計將推動市場的成長

全球人口格局正經歷快速老化趨勢，老年人口數量顯著增加。這種人口結構的變化使老年人認知障礙的風險升高，包括阿茲海默症和各種形式的失智症。世界衛生組織預計，到 2030 年，全球六分之一的人將年齡在 60 歲或以上。因此，60歲及以上人口預計將從2020年的10億增加到14億。認知的提高和診斷方法的進步有助於提高認知障礙的識別率。隨著診斷技術的發展，更多的病例在早期階段被識別和診斷——此外，持續的技術創新和醫療基礎設施的擴展為市場成長提供了重大機會。然而，標準化的缺乏可能會對市場的擴張帶來挑戰。

認知診斷市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 27.90% 左右的複合年成長率成長

按地區分類，北美是 2023 年的主要收入來源

認知診斷市場區隔分析：

全球認知診斷市場根據診斷、適應症、最終用戶和地區進行細分。

根據診斷，市場分為八個不同的類別：腦部影像測試、實驗室測試、精神狀態測試、快速家庭篩檢測試、神經心理測試、腦電圖(EEG)、認知功能和行為測試以及神經精神問卷調查(NPI-問）。這些診斷類別中的每一個對於在認知健康領域提供徹底的評估和提高患者的治療效果至關重要。

根據適應症，市場分為兩類：阿茲海默症、失智症和其他神經系統疾病。每個類別都包括用於評估和治療這些病症的不同診斷工具和方法。

根據最終用戶，市場分為兩類：醫院、神經科診所、復健中心、學術和研究機構、家庭護理等。每個最終用戶組都採用根據其特定要求和環境量身定做的不同診斷工具和技術。

認知診斷市場-地理洞察

市場地理分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲。出於商業目的，這些區域按國家進一步細分。由於對評估認知表現的診斷工具和技術的需求不斷成長，北美引領了市場成長。該地區是技術進步的先驅，特別是在人工智慧 (AI) 和機器學習方面。這些技術正在被納入認知診斷工具中，提高其精確度和有效性。皮尤研究中心進行的一項調查顯示，55% 的美國人聲稱經常使用人工智慧，而 44% 的人認為他們不經常使用人工智慧。由於對個人化醫療的需求不斷成長，歐洲成為第二大市場成長地區。

認知診斷市場-競爭格局：

認知診斷市場競爭非常激烈，許多競爭對手都在努力透過技術進步、策略聯盟和產品獨特性來獲得市場佔有率。各組織正在投入大量資源進行研究和開發，以引入創新的診斷儀器和技術。這包括大腦成像、生物標記分析和人工智慧驅動的診斷系統的進展。企業正在透過進入新興市場並在認知診斷需求不斷成長的地區建立業務來擴大市場範圍。這包括建立新設施、收購當地實體以及客製化產品以滿足地區需求。公司透過創造獨特的診斷儀器、提高精度、方便用戶使用的介面以及與其他醫療保健技術的無縫整合而脫穎而出。這包括提供全面的診斷解決方案，解決認知評估的各個方面。

概述
- 透過診斷進行細分市場佔有率分析
- 腦部影像測試
  - 磁振造影 (MRI)
  - 電腦斷層掃描 (CT)
  - 正子斷層掃描 (PET) 和 PET/CT
- 實驗室測試
  - 腦脊髓液（CSF）
  - 血液檢查
- 心理狀態測試
  - 簡易精神狀態檢查 (MMSE)
  - 蒙特婁認知評估 (MoCA)
- 快速居家篩檢測試
- 神經心理測試
- 腦電圖（EEG）
- 認知功能和行為測試
- 神經精神問卷 (NPI-Q)

第 8 章：認知診斷市場 - 依適應症分類

概述
- 按指標分類的細分市場佔有率分析
- 阿茲海默症
- 失智
- 其他神經系統疾病

第 9 章：認知診斷市場 - 按最終用戶

概述
- 按最終用戶分類的細分市場佔有率分析
- 醫院
- 神經內科診所
- 復健中心
- 學術及研究機構
- 居家護理
- 其他

第 10 章：認知診斷市場 - 按地理位置

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美認知診斷主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模及預測（按診斷）
- 北美市場規模和預測（按指標）
- 北美市場規模和預測（按最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲認知診斷主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模和預測（透過診斷）
- 歐洲市場規模與預測（按指標）
- 歐洲市場規模和預測（按最終用戶）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區認知診斷主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模及預測（依診斷）
- 亞太地區市場規模與預測（依指標）
- 亞太地區市場規模和預測（按最終用戶）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲認知診斷主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按診斷）
- 拉丁美洲市場規模與預測（按指標）
- 拉丁美洲市場規模和預測（按最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲認知診斷主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按診斷）
- 中東和非洲市場規模及預測（依指標）
- 中東和非洲市場規模和預測（按最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 認知診斷產業

競爭儀表板
公司簡介
- Cognetivity Neurosciences
- Cognivue
- Cogstate
- Cambridge Cognition
- Diadem
- CN Diagnostics
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV3591

REPORT HIGHLIGHT

Cognitive Diagnostics Market size was valued at USD 5,390.21 million in 2023, expanding at a CAGR of 27.90% from 2024 to 2032.

Cognitive diagnostic models are a psychometric paradigm for designing and scoring tests to provide a profile of examinee skill mastery rather than just an overall test score. Cognitive diagnostics refers to the assessment and evaluation of cognitive functions, which include memory, attention, language, problem-solving, and other intellectual abilities. This field encompasses various techniques, tools, and technologies used to diagnose cognitive impairments and disorders, such as Alzheimer's disease, dementia, ADHD, and other neurological conditions. Cognitive diagnostics play a crucial role in the management and treatment of cognitive disorders, offering valuable insights into brain health and function. As technology advances, the field is expected to grow, providing more accurate, accessible, and affordable diagnostic options.

Cognitive Diagnostics Market- Market Dynamics

The growing geriatric population and increasing prevalence of cognitive disorders globally are expected to drive the growth of the market

The global demographic landscape is experiencing a swift aging trend, marked by a notable rise in the elderly population. This demographic shift places older adults at an elevated risk for cognitive impairments, including Alzheimer's disease and various forms of dementia. The World Health Organization projects that by the year 2030, one in six individuals worldwide will be aged 60 years or older. Consequently, the population segment aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion. Enhanced awareness and advancements in diagnostic methods are contributing to higher rates of identification for cognitive disorders. As diagnostic technologies evolve, more cases are being recognized and diagnosed at earlier stages-additionally, the ongoing technological innovations and the expansion of healthcare infrastructure present significant opportunities for market growth. Nevertheless, the absence of standardization may pose challenges to the market's expansion.

Cognitive Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 27.90% over the forecast period (2024-2032)

Based on region, North America was the leading revenue generator in 2023

Cognitive Diagnostics Market- Segmentation Analysis:

The Global Cognitive Diagnostics Market is segmented based on Diagnosis, Indication, End-User, and Region.

The market is segmented into eight distinct categories according to Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function & Behavioral Tests, and the Neuropsychiatric Inventory Questionnaire (NPI-Q). Each of these diagnostic categories is essential for delivering thorough evaluations and enhancing patient outcomes in the realm of cognitive health.

The market is segmented into two categories according to Indication: Alzheimer's disease, Dementia, and other neurological disorders. Each category includes distinct diagnostic tools and methods for evaluating and treating these conditions.

The market is segmented into two groups according to End-User: Hospitals, Neurology Clinics, Rehabilitation Centers, Academic and Research Institutes, Home Care, and Others. Each end-user group employs different diagnostic tools and techniques customized to their particular requirements and environments.

Cognitive Diagnostics Market- Geographical Insights

The market is geographically spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries for business purposes. North America leads the market growth, driven by the increasing demand for diagnostic tools and technologies to assess cognitive performance. The region is a pioneer in technological advancements, especially in artificial intelligence (AI) and machine learning. These technologies are being incorporated into cognitive diagnostic tools, improving their precision and effectiveness. A survey conducted by Pew Research revealed that 55% of Americans claim to regularly use AI, while 44% believe they do not use it regularly. Europe follows as the second largest region for market growth, attributed to the rising demand for Personalized Medicine.

Cognitive Diagnostics Market- Competitive Landscape:

The cognitive diagnostics market is fiercely competitive, with a wide array of competitors striving to gain market share through technological advancements, strategic alliances, and product distinctiveness. Organizations are dedicating significant resources to research and development to introduce innovative diagnostic instruments and technologies. This encompasses progress in brain imaging, biomarker analysis, and AI-powered diagnostic systems. Businesses are broadening their market reach by venturing into emerging markets and establishing a presence in regions where there is a growing demand for cognitive diagnostics. This involves establishing new facilities, acquiring local entities, and customizing products to suit regional requirements. Companies set themselves apart by creating unique diagnostic instruments, enhancing precision, user-friendly interfaces, and seamless integration with other healthcare technologies. This includes providing comprehensive diagnostic solutions that address various aspects of cognitive evaluation.

Recent Developments:

C2N Diagnostics, a prominent entity in the field of advanced brain health diagnostics known for its PrecivityAD blood test, which assists in the diagnosis of Alzheimer's disease, has unveiled its latest innovative product. This new offering is expected to significantly improve care for individuals experiencing cognitive impairment: a high-resolution mass spectrometry-based plasma tau multi-analyte assay (p-tau MAA) designated for Research Use Only (RUO).

Cognetivity Neurosciences Ltd., a technology company specializing in brain health screening platforms for medical, commercial, and consumer settings, is excited to share that its leading CognICA tool has proven to be effective in monitoring cognitive function in Alzheimer's disease patients undergoing treatment with the disease-modifying therapy Aduhelm (aducanumab) from Biogen.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COGNITIVE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Cognetivity Neurosciences
Cognivue
Cogstate
Cambridge Cognition
Diadem
CN Diagnostics
Others

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

Brain Imaging Tests
Magnetic Resonance Imaging (MRI)
Computerized Tomography (CT)
Positron Emission Tomography (PET) and PET/CT
Laboratory Testing
Cerebrospinal fluid (CSF)
Blood Tests
Mental Status Testing
Mini-Mental State Exam (MMSE)
Montreal Cognitive Assessment (MoCA)
Rapid Home Screening Tests
Neuropsychological Testing
Electroencephalogram (EEG)
Cognitive Function & Behavioral Tests
Neuropsychiatric Inventory Questionnaire (NPI-Q)
GLOBAL COGNITIVE DIAGNOSTICS MARKET, INDICATION BY - MARKET ANALYSIS, 2019 - 2032
Alzheimer's disease
Dementia
Others neurological disorders

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Neurology Clinics
Rehabilitation Centers
Academic and Research Institutes
Home Care
Others

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Cognitive Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cognitive Diagnostics Market Snippet by Diagnosis
- 2.1.2. Cognitive Diagnostics Market Snippet by Indication
- 2.1.3. Cognitive Diagnostics Market Snippet by End-User
- 2.1.4. Cognitive Diagnostics Market Snippet by Country
- 2.1.5. Cognitive Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Cognitive Diagnostics Key Market Trends

3.1. Cognitive Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cognitive Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cognitive Diagnostics Market Opportunities
3.4. Cognitive Diagnostics Market Future Trends

4. Cognitive Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cognitive Diagnostics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Cognitive Diagnostics Market Landscape

6.1. Cognitive Diagnostics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cognitive Diagnostics Market - By Diagnosis

7.1. Overview
- 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
- 7.1.2. Brain Imaging Tests
  - 7.1.2.1. Magnetic Resonance Imaging (MRI)
  - 7.1.2.2. Computerized Tomography (CT)
  - 7.1.2.3. Positron Emission Tomography (PET) and PET/CT
- 7.1.3. Laboratory Testing
  - 7.1.3.1. Cerebrospinal fluid (CSF)
  - 7.1.3.2. Blood Tests
- 7.1.4. Mental Status Testing
  - 7.1.4.1. Mini-Mental State Exam (MMSE)
  - 7.1.4.2. Montreal Cognitive Assessment (MoCA)
- 7.1.5. Rapid Home Screening Tests
- 7.1.6. Neuropsychological Testing
- 7.1.7. Electroencephalogram (EEG)
- 7.1.8. Cognitive Function & Behavioral Tests
- 7.1.9. Neuropsychiatric Inventory Questionnaire (NPI-Q)

8. Cognitive Diagnostics Market - By Indication

8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
- 8.1.2. Alzheimer's disease
- 8.1.3. Dementia
- 8.1.4. Others neurological disorders

9. Cognitive Diagnostics Market - By End-User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Neurology Clinics
- 9.1.4. Rehabilitation Centers
- 9.1.5. Academic and Research Institutes
- 9.1.6. Home Care
- 9.1.7. Others

10. Cognitive Diagnostics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Cognitive Diagnostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Cognitive Diagnostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Cognitive Diagnostics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Cognitive Diagnostics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Cognitive Diagnostics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cognitive Diagnostics Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Cognetivity Neurosciences
- 11.2.2. Cognivue
- 11.2.3. Cogstate
- 11.2.4. Cambridge Cognition
- 11.2.5. Diadem
- 11.2.6. CN Diagnostics
- 11.2.7. Others